Goldman Sachs Group Inc Merck & Co., Inc. Call Options Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $43 Million - $49.9 Million	386,800 Added 700.72%	442,000 $50.2 Million
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $11.2 Million - $12 Million	-90,500 Reduced 62.11%	55,200 $6.83 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $25.7 Million - $29.9 Million	-226,900 Reduced 60.9%	145,700 $19.2 Million
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $32.5 Million - $35.4 Million	-324,400 Reduced 46.54%	372,600 $40.6 Million
Q3 2023 May 14, 2024	BUY	$102.95 - $114.33 $33.4 Million - $37.1 Million	324,400 Added 87.06%	697,000 $71.8 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $50.8 Million - $56.4 Million	-493,100 Reduced 41.43%	697,000 $71.8 Million
Q2 2023 May 14, 2024	BUY	$108.61 - $118.38 $115 Million - $125 Million	1,054,400 Added 777.01%	1,190,100 $137 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $115 Million - $125 Million	1,054,400 Added 777.01%	1,190,100 $137 Million
Q1 2023 May 14, 2024	SELL	$102.94 - $114.86 $988,224 - $1.1 Million	-9,600 Reduced 6.61%	135,700 $14.4 Million
Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $988,224 - $1.1 Million	-9,600 Reduced 6.61%	135,700 $14.4 Million
Q4 2022 May 14, 2024	SELL	$87.44 - $112.11 $43.6 Million - $55.8 Million	-498,100 Reduced 77.42%	145,300 $16.1 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $43.6 Million - $55.8 Million	-498,100 Reduced 77.42%	145,300 $16.1 Million
Q3 2022 May 14, 2024	SELL	$84.53 - $94.96 $17.9 Million - $20.1 Million	-211,400 Reduced 24.73%	643,400 $55.4 Million
Q3 2022 Nov 10, 2022	SELL	$84.53 - $94.96 $17.9 Million - $20.1 Million	-211,400 Reduced 24.73%	643,400 $55.4 Million
Q2 2022 May 14, 2024	BUY	$83.49 - $94.64 $40.3 Million - $45.6 Million	482,200 Added 129.41%	854,800 $77.9 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $3.21 Million - $3.63 Million	-38,400 Reduced 4.3%	854,800 $77.9 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $6.78 Million - $7.61 Million	-92,300 Reduced 9.37%	893,200 $73.3 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $68.6 Million - $85.9 Million	948,700 Added 2577.99%	985,500 $75.5 Million
Q3 2021 Nov 10, 2021	BUY	$71.68 - $78.83 $2.64 Million - $2.9 Million	36,800 New	36,800 $2.76 Million

Others Institutions Holding MRK

# of Institutions

3,819

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$24.3 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$20.2 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$11.6 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.39 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$5.76 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account